Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moulin

Showing results (171-180 of 188) with videos related to

Pageof 19
Sort By:
Data in Brief|November 21, 2018
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic scorePhilippe Moulin, Robert Dufour, Maurizio Averna, et al.
Cardiovascular Research|June 3, 2025
A rare gain of function variant of hepatic lipase attenuates hypercholesterolaemia and atherosclerosis in mice via an LDL receptor-independent mechanismThibaud Sotin, Xiaoke Ge, Milena Schönke, et al.
Atherosclerosis|July 7, 2018
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score"Philippe Moulin, Robert Dufour, Maurizio Averna, et al.
Circulation|July 28, 2022
Identification of a Gain-of-Function <i>LIPC</i> Variant as a Novel Cause of Familial Combined HypocholesterolemiaWieneke Dijk, Mathilde Di Filippo, Sander Kooijman, et al.
Atherosclerosis|November 5, 2024
The singular French PCSK9-p.Ser127Arg gain-of-function variant: A significant player in cholesterol levels from a 775-year-old common ancestorYara Azar, Thomas E Ludwig, Hugo Le Bon, et al.
The New England Journal of Medicine|April 13, 2017
Autoantibodies against GPIHBP1 as a Cause of HypertriglyceridemiaAnne P Beigneux, Kazuya Miyashita, Michael Ploug, et al.
Journal of Clinical Lipidology|October 15, 2022
Guidance for the diagnosis and treatment of hypolipidemia disordersCindy Bredefeld, M Mahmood Hussain, Maurizio Averna, et al.
European Heart Journal|September 2, 2021
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis SocietyHenry N Ginsberg, Chris J Packard, M John Chapman, et al.
Journal of Hepatology|May 21, 2014
Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemiaMathilde Di Filippo, Philippe Moulin, Pascal Roy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 1, 2022
Variants in the <i>GPR146</i> Gene Are Associated With a Favorable Cardiometabolic Risk ProfileAntoine Rimbert, Ming W Yeung, Nawar Dalila, et al.
Pageof 19

Showing results (171-180 of 188) with videos related to

Sort By:
Pageof 19
Data in Brief|November 21, 2018
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic scorePhilippe Moulin, Robert Dufour, Maurizio Averna, et al.
Cardiovascular Research|June 3, 2025
A rare gain of function variant of hepatic lipase attenuates hypercholesterolaemia and atherosclerosis in mice via an LDL receptor-independent mechanismThibaud Sotin, Xiaoke Ge, Milena Schönke, et al.
Atherosclerosis|July 7, 2018
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score"Philippe Moulin, Robert Dufour, Maurizio Averna, et al.
Circulation|July 28, 2022
Identification of a Gain-of-Function <i>LIPC</i> Variant as a Novel Cause of Familial Combined HypocholesterolemiaWieneke Dijk, Mathilde Di Filippo, Sander Kooijman, et al.
Atherosclerosis|November 5, 2024
The singular French PCSK9-p.Ser127Arg gain-of-function variant: A significant player in cholesterol levels from a 775-year-old common ancestorYara Azar, Thomas E Ludwig, Hugo Le Bon, et al.
The New England Journal of Medicine|April 13, 2017
Autoantibodies against GPIHBP1 as a Cause of HypertriglyceridemiaAnne P Beigneux, Kazuya Miyashita, Michael Ploug, et al.
Journal of Clinical Lipidology|October 15, 2022
Guidance for the diagnosis and treatment of hypolipidemia disordersCindy Bredefeld, M Mahmood Hussain, Maurizio Averna, et al.
European Heart Journal|September 2, 2021
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis SocietyHenry N Ginsberg, Chris J Packard, M John Chapman, et al.
Journal of Hepatology|May 21, 2014
Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemiaMathilde Di Filippo, Philippe Moulin, Pascal Roy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 1, 2022
Variants in the <i>GPR146</i> Gene Are Associated With a Favorable Cardiometabolic Risk ProfileAntoine Rimbert, Ming W Yeung, Nawar Dalila, et al.
Pageof 19